company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9208000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9208000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1111000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6521000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19012000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20588000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20588000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-737000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-131955000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,102738000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29954000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29954000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,763000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,763000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,763000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49783000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7791000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7791000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1136000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5423000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15637000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16869000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16869000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1265000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-81396000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,138280000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,55619000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,55619000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,635000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,635000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,635000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39381000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2009.0,Q4,2009-10-01,2009-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-5836000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14632000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14632000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1223000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8896000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19801000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24314000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24314000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1430000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100965000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75432000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26963000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26963000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2541000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2541000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2541000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48765000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9630000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9630000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1266000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6228000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21902000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24038000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24038000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1067000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-105417000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,111168000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4684000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4684000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,53000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,53000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19301000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6930000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6930000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1291000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1020000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15769000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20388000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20388000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1138000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-102980000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,151697000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,47579000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,47579000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,527000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,527000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,527000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27718000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-5767000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16285000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16285000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1339000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5332000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3309000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6305000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6305000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41790000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64105000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22287000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22287000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:01:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15991000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13824000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13824000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1287000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5362000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19404000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26579000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26579000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-474000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-121969000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125080000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2637000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2637000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,462000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,462000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23480000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13237000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13237000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1262000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5439000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22489000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29025000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29025000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-265000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54062000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90578000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,36251000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,36251000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7226000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14303000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14303000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1237000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5251000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17344000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25159000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25159000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-524000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-75294000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96602000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20784000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20784000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,267000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,267000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,267000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4108000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10657000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11368000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11368000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2121000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3966000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24934000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30215000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30215000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-118210000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53042000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-162000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65593000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65593000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-328000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87647000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,87319000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,87319000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:00:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8489000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12956000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12956000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8738000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21694000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21694000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1670000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38894000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,48165000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7601000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7601000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,328000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,628000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-328000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,628000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,628000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13465000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19502000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19502000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24714000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5212000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5212000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5729000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38568000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62150000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17853000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17853000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4499000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4499000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4499000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27564000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62188000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62188000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2024000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-22509000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13761000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-68912000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-68912000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-686000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-81457000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125656000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,43513000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,43513000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,997000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-31000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,966000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,966000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24433000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-17000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9013000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9013000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2127000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2825000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3090000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-971000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-971000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1799000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-187077000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58036000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-130840000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-130840000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,178210000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,178210000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,178210000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,46399000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18169000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18169000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2711000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,620000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8764000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23602000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23602000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-379000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-87351000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34521000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53209000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53209000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3982000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3982000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3982000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-72829000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29686000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29686000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2764000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6679000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1472000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21715000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21715000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-950000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60769000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59215000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2504000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2504000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11084000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11084000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13135000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32357000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32357000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2627000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8537000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1176000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22369000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22369000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-878000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29108000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,86034000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,56048000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,56048000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7650000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7650000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41329000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-11000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-250943000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-250943000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2600000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,212534000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5866000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41675000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41675000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-388000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-487598000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,133206000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-379780000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-379780000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,734578000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15703000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,718875000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,718875000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:13:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,297420000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44074000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44074000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2868000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3650000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9069000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-46625000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-46625000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1852000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-280912000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54389000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-228375000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-228375000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5138000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5138000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5138000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-269862000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43989000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43989000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3117000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6033000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5867000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40706000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40706000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3195000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84163000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125264000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37906000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37906000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5056000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-262000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4794000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4794000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1994000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21389000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21389000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3341000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8047000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10540000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36635000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36635000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3526000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125102000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,150063000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21435000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21435000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7685000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-27000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7658000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7658000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7542000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-517000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50777000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50777000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3690000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8052000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12780000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26255000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26255000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2110000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-507617000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,168687000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-288000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-341328000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-341328000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,598984000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,598984000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,598984000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:46:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,231401000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71783000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71783000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5021000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10884000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,422000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-55456000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-55456000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1264000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-310341000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,204381000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,288000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-106936000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-106936000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7074000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7074000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-155318000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-76792000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-76792000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5270000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12102000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5055000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-54365000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-54365000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6477000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-80371000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,135518000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,48670000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,48670000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3651000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3651000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2044000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90721000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90721000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5069000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16103000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16485000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-53064000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-53064000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3099000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-136985000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,218357000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,78273000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,78273000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6468000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6468000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31677000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,66000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-102974000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-102974000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4601000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18655000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3905000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-83623000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-83623000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11816000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-164561000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,294317000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,117940000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,117940000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16125000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-59000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16066000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16066000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 08:36:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,50383000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90129000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90129000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4011000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15312000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,601000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-70205000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-70205000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12564000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-343431000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,311660000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44335000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44335000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,150000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4442000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,222000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,154338000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,154338000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39798000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-104071000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-104071000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3500000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17441000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7594000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-75536000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-75536000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20298000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-257671000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,246564000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31405000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31405000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4346000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4346000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-102595000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-112934000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-112934000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3018000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20795000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10784000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-78337000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-78337000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19879000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-143647000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,263917000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,100391000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,100391000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3082000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3082000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25136000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1096000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,111000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-107290000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-107290000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17817000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13857000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-100330000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-100330000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36152000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-86803000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,198031000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,75076000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,75076000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2769000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-53000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2716000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2716000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 17:04:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22538000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-118420000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-118420000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3066000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24898000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9407000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-81049000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-81049000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21651000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-150381000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104361000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-67671000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-67671000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,386406000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,200000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,386606000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,386312000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,237592000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-122937000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-122937000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3587000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,26616000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5629000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-98363000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-98363000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25678000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-274842000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,163342000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-137178000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-137178000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28956000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28997000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28915000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-206626000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-142227000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-142227000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2245000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25382000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11556000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-103044000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-103044000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20728000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-391431000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,251571000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-160588000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-160588000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-120000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,826760000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-188000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,706572000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,706948000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,443316000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2430000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,114000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-141214000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-141214000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3178000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20526000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-38154000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-155664000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-155664000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21257000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-358433000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,244876000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-134814000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-134814000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42094000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-572000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,41522000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,41522000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:31:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-248956000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-163560000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-163560000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2239000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16061000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,42573000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-102687000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-102687000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22708000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-299179000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,384508000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,62621000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,62621000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5641000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-60000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5581000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5581000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34485000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-245282000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-245282000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,405000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,98401000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7332000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-153808000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-153808000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45409000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-349598000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,491181000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,96174000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,96174000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12357000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,632000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12989000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12989000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-44645000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-211441000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-211441000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9426000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,34550000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17008000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-150457000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-150457000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37513000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-111661000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,398138000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,248964000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,248964000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5378000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5378000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5378000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,103885000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,775000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1066000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-181915000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-181915000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3838000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10255000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,36716000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-57404000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-188510000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-188510000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44049000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-256996000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,403697000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,102652000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,102652000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,390931000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,390931000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,390931000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 08:47:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,305073000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-219481000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-219481000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18117000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-10255000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,46688000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,453626000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,288695000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,288695000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21244000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-577567000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,309409000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-289402000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-289402000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,412694000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,84000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,412778000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,412610000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,411903000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-208535000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-208535000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-10222000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,27873000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,57572000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-49320000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-182632000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-182632000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36058000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-611069000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,637050000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10077000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10077000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-20699000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-213408000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-276185000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-276185000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5442000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9320000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19044000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,46399000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-195980000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-195980000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-38805000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-630293000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,455248000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-220850000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-220850000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-359658000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,400000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,40342000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,40342000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-376488000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,172000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2566000.0
